BARD1 has an experienced board and management team with a track record in building successful companies, and international expertise in BARD1 biology, biomarker translation and respiratory medicine.
Peter Gunzburg BCom | Executive Chairman
Peter Gunzburg is a public company director, stockbroker and technology investor, with over 20 years corporate advisory, capital raising, transaction and business management experience. Peter is currently Chair of the Institute for Respiratory Health at UWA, and has previously been a director of Resolute Ltd, Australian Stock Exchange Ltd, Eyres Reed Ltd, CIBC World Markets Australia Ltd, Fleetwood Corporation Ltd, Dragon Mining Ltd and Newzulu Ltd.
Dr Irmgard Irminger-Finger PD PhD | Executive Director & Chief Scientific Officer
Dr Irminger-Finger is founder and co-inventor of BARD1 and its technology. She has more than 15 years of experience in biotech as founder, director, and chair, as recipient of Swiss start up awards, and as one of five finalists of the 2014 European Woman Entrepreneur Award. She is an internationally recognised expert in tumor biology with over 100 publications, multiple international collaborations and many keynote presentations at international conferences. Irmgard has a Masters degree in molecular biology and a PhD in molecular genetics from the University of Zurich, and was an award research fellow at the Harvard University. She holds a tenured faculty position at the University (UNIGE) and University Hospital of Geneva (HUG) and Adjunct Professorship at the University of Western Australia (UWA).
Brett Montgomery | Non-Executive Director
Brett Montogomery has extensive experience in public company management, leadership, corporate governance and risk management. Brett is currently Non-Executive Director of Tanami Gold NL, and Magnum Gas and Power Ltd. He was previously Managing Director of Kalimantan Gold NL, and Director of Grants Patch Mining Ltd and EZA Corporation Ltd.
Prof Geoff Laurent PhD FRCP(Hon) FRCPath FMedSci | Non-Executive Director
Professor Geoffrey Laurent is an accomplished organisational leader, thought-leader, scientific editor, advisory board member, and award winning respiratory scientist with over 300 peer reviewed publications. Geoff is currently Director of the Institute for Respiratory Health, and Director of the Centre of Cell Therapy and Regenerative Medicine at the University of Western Australia. He is also a Fellow of the Academy of Medical Sciences, and Editor-in-Chief of the International Journal of Biochemistry and Cell Biology. Prior to this he was Vice-Dean of Enterprise and Head of Department of Internal Medicine at University College London, and Past President of the British Association for Lung Research. Geoff was awarded the European Respiratory Societies Presidential Award for his contribution to lung science.
Dr Leearne Hinch BSc BVMS MBA | Chief Executive Officer
Dr Leearne Hinch is a biotechnology executive and consultant with extensive experience in the life science industry in general management, strategy, fundraising, business development and commercialisation. Leearne has strategic, operational and technical experience leading and managing the development and commercialisation of drug, device and animal health products. She is director of commercialisation advisory Ingeneus Solutions, and previously held CEO and executive positions in ASX-listed biotechnology, multinational and private companies including Eustralis Pharmaceuticals Ltd, Immuron Ltd, OBJ Ltd, Holista CollTech Ltd, Chemeq Ltd and Virbac (Australia) Pty Ltd.